The Use of Release-Active Antibody-Based Preparations for Vertigo Prevention in Adults.

Related Articles

The Use of Release-Active Antibody-Based Preparations for Vertigo Prevention in Adults.

Bull Exp Biol Med. 2015 Nov;160(1):61-3

Authors: Barchukov VV, Zhavbert ES, Dugina YL, Epstein OI

Abstract
The effectiveness of antibody-based release-active preparations Impaza (antibodies to eNOS), Tenoten (antibodies to brain-specific protein S-100), Dietressa (antibodies to type 1 cannabinoid receptor), Brizantin (combined preparation, antibodies to brain-specific protein S-100 and type 1 cannabinoid receptor), and Divaza (combined preparation, antibodies to brain-specific protein S-100 and eNOS) in the prevention of vertigo was studied on the model of intermittent accumulation of Coriolis accelerations (ICCA). Modification of activity of vestibular receptors and signal systems by release-active preparations contributed to an increase in ICCA tolerance time. Combined preparation Impaza possessed the most significant antinaupathic properties. Brizantin was less potent in this respect.

PMID: 26608378 [PubMed - indexed for MEDLINE]

from Hearing and Balance via ola Kala on Inoreader http://ift.tt/2dodV39
via IFTTT